Background. Our interest in immunological effects produced by vitamin D 3 (1,25(OH) 2 D 3 ) and its therapeutic potential prompted us to examine the role of 1,25(OH) 2 D 3 on cytokine production by Candida albicans.Methods. Peripheral blood mononuclear cells (PBMC) with stimulated C. albicans and 1,25(OH) 2 D 3 , cytokine concentrations were measured in supernatant. Quantitative polymerase chain reaction (qPCR) was performed for T cell transcription factors, SOCS1 and 3. TLR2/4, Dectin-1, and mannose receptor expression was studied using flow cytometry and qPCR. An ex-vivo stimulation study was carried out in healthy volunteers to investigate the seasonality of immune response to C. albicans.Results. Upon in vitro C. albicans stimulation, 1,25(OH) 2 D 3 induced a dose-dependent, down-regulation of IL-6, TNFa, IL-17, and IFNc. It also increased IL-10 production. The shift in cytokine profile was not due to 1,25(OH) 2 D 3 augmenting expression of either Thelper differentiation factors or SOCS1 and SOCS3 mRNA. 1,25(OH) 2 D 3 inhibited TLR2, TLR4, Dectin-1, and MR mRNA and protein expression. In our seasonality study, both IL-17 and IFNc levels were suppressed in summer when 25(OH)D 3 levels were elevated.Conclusion. Vitamin D 3 skews cytokine responses toward an antiinflammatory profile, mediated by suppression of TLR2, TLR4, Dectin-1, and MR transcription, leading to reduced surface expression. The biological relevance of these effects has been confirmed by the seasonality of cytokine responses.